Abstract
Matrix metalloproteinase 19 (MMP-19) is able to process various proteins of the basement membrane. To investigate the impact of MMP-19 activity on endothelial cells in the context of tumor extracellular matrix (ECM), we treated Matrigel matrix with an active recombinant MMP-19 and analyzed its effect on capillary-like formation. Human microvascular endothelial cells (HMEC-1) could not form capillary-like formation on Matrigel treated with recombinant MMP-19. Analyzing the Matrigel proteins, we found that MMP-19 preferentially cleaved nidogen-1. The cleavage site of nidogen-1 was mapped to Thr867-Leu868. This cleavage separates the G3 globular domain containing the binding site for the γ1 chain of laminin-1 and collagen IV and thus abolishes the capacity of nidogen-1 to cross-link ECM proteins. Anti-nidogen antibodies directed against the G3 domain of nidogen-1 inhibited the capillary-like structure formation to a similar extent as MMP-19. Since nidogen-1 is thought to stabilize microvessels, MMP-19 might be one of the enzymes that interferes with stabilization or maturation of nascent vasculature.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 10 March 2004; received after revision 30 April 2004; accepted 26 May 2004
Rights and permissions
About this article
Cite this article
Titz, B., Dietrich, S., Sadowski, T. et al. Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1. CMLS, Cell. Mol. Life Sci. 61, 1826–1833 (2004). https://doi.org/10.1007/s00018-004-4105-0
Issue Date:
DOI: https://doi.org/10.1007/s00018-004-4105-0